Geneos Wealth Management’s Vanguard S&P Small-Cap 600 Value ETF VIOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-372,978
Closed -$33M 3125
2021
Q1
$33M Buy
+372,978
New +$30.5M 0.92% 18
2018
Q4
Sell
-3,500
Closed -$251K 2488
2018
Q3
$251K Hold
3,500
0.02% 564
2018
Q2
$246K Hold
3,500
0.02% 514
2018
Q1
$228K Hold
3,500
0.02% 509
2017
Q4
$231K Hold
3,500
0.02% 497
2017
Q3
$223K Hold
3,500
0.02% 485
2017
Q2
$211K Buy
3,500
+800
+30% +$47.7K 0.02% 487
2017
Q1
$161K Buy
2,700
+2,300
+575% +$138K 0.02% 532
2016
Q4
$24K Buy
+400
New +$22.5K ﹤0.01% 1115

Other funds holding VIOV

Geneos Wealth Management's VIOV Position: Q2 2021 in Review

Geneos Wealth Management sold out of Vanguard S&P Small-Cap 600 Value ETF (VIOV) in Q2 2021, closing a stake of 372,978 shares — an estimated $33M sold.

Geneos Wealth Management first reported a position in VIOV in Q4 2016 and held it in 9 quarters. The position peaked at $33M in Q1 2021. 133 funds tracked by Wall St. Rank hold VIOV as of Q2 2021.

  • Geneos Wealth Management reported no remaining Vanguard S&P Small-Cap 600 Value ETF position as of Q2 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 372,978 Vanguard S&P Small-Cap 600 Value ETF shares in Q2 2021, an estimated $33M.
  • Geneos Wealth Management first reported a position in Vanguard S&P Small-Cap 600 Value ETF in Q4 2016 and held it in 9 quarters.
  • Geneos Wealth Management's Vanguard S&P Small-Cap 600 Value ETF position peaked at $33M in Q1 2021.
  • 133 funds tracked by Wall St. Rank held Vanguard S&P Small-Cap 600 Value ETF as of Q2 2021.

Based on Geneos Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.